Improving Medication Adherence in Hypertensive Patients (HTNmobile)

Duke University

Status: Withdrawn

Conditions: Hypertension

Treatments: Behavioral: Electronic Intervention

Study type: Interventional

Funder types: Other

Identifiers

NCT01826435

Pro00043793

Details and patient eligibility

About

The study team is proposing a single arm intervention to test the effect of an electronic intervention on medication use among individuals with a prescription for hypertension/high blood pressure. The investigator proposes that technology like text messaging, email, web applications and mobile apps with proven, nurse intervention scripts, will lead to significant, cost-effective improvements in hypertension medication use.

Full description

The intervention will incorporate a scalable electronic intervention using Email/Web Apps and Short Message Service (SMS)/Mobile Web Apps. The study team will examine the participants' responses to the electronic encounters in the technology-only intervention throughout the 3-month study timeframe.

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Enrolled in the primary care clinic for the past 6 months
• New or existing prescription for hypertension
• Poorly controlled mean systolic blood pressure (SBP) in the last 12 months (>140/90 Hg)

Exclusion criteria

• Hospitalized for a stroke, myocardial infarction, coronary artery revascularization in the past 3 months,
• Diagnosis of metastatic cancer;
• Active diagnosis of psychosis or dementia documented in medical record;
• Does not have access to the appropriate technology required
• Is not willing to use said device to receive notifications for the study;
• Does not live independently (assisted living or nursing home residents) or otherwise institutionalized or receiving home health care
• Severely impaired hearing, vision or speech (unless technological aides allow them full functionality)
• Planning to leave the area or change primary care clinics prior to the anticipated end of participation;
• Unable to read and understand spoken English
• Participation in another cardiovascular disease (CVD) study
• Another household member enrolled in study;
• Arm size > 50cm

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

Electronic Intervention

Experimental group

Description:

Over the three months, participants will receive a technology intervention. This will include text or email encounter notifications associated with appropriate mobile or online self-management information for medication adherence and behavior change.

Treatment:

Behavioral: Electronic Intervention